Announcement of GUDID Release 2.2 Deployment and Document Updates

By AHRMM

GUDID Release 2.2 was successfully deployed. The enhancements will allow for additional functionality as noted below.

  • Labelers will be able to “unlock” their device records after the DI record grace period to make error corrections. This will eliminate the need to contact the FDA UDI Help Desk to make corrections after the grace period.

Note that the Unlock functionality is intended to be used to correct data submission errors after the grace period. DO NOT USE Unlock functionality for edits that require assignment of a NEW Device Identifier. Please assign a new Device Identifier and submit a new record if you are changing data elements that are “New DI Triggers” (i.e., not correcting submission errors)

  • Addition of new data elements to the GUDID download file made available on AccessGUDID and OpenFDA to include –
  • Public Version Number
  • Public Version Date
  • Public Version Status (new/update/delete)
  • Public Device Record Key
  • Labeler DUNS Number
  • Premarket Submission Number & Supplement Number – note that this will be released after the testing/review period as indicated here.

GUDID documents (listed below) have been updated as of March 30, 2018.

We have also updated the GUDID System Enhancements and Fixes page to reflect all releases to-date.

If you have questions, concerns or feedback, please contact the FDA UDI Help Desk.

 

Related Resources

Supply Chain Strategies & Solutions Article
Supply chain departments in healthcare organizations can add significant value to their procure-to-pay process by integrating their enterprise reso
White Papers
This paper will define the regulation and explore how a supply chain department can support their organization in meeting this aspect of the regu
Supply Chain Strategies & Solutions Article
Case Studies
A UDI Capture Work Group Case Study at the Baptist Health.
Webcast
In part one, we explore the reasons why the FDA created the (UOU) Unit of Use.
Webcast
In the third part of the the FDA Unique Device Identification (UDI) “Unit of Use” (UOU) webcast series, we cover several potential use cases for th